Prognostic impact of activin subunit inhibin beta A in gastric and esophageal adenocarcinomas

PURPOSE: Adenocarcinomas of the esophagus (AEG) and stomach (AS) are among the most common cancers worldwide. Novel markers for risk stratification and guiding treatment are strongly needed. Activin is a multi-functional cytokine with context specific pro- and anti-tumorigenic effects. We aimed to i...

Descripción completa

Detalles Bibliográficos
Autores principales: Staudacher, J. J., Arnold, Alexander, Kühl, A. A., Pötzsch, M., Daum, S., Winterfeld, M., Berg, E., Hummel, M., Rau, B., Stein, U., Treese, C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9446826/
https://www.ncbi.nlm.nih.gov/pubmed/36064338
http://dx.doi.org/10.1186/s12885-022-10016-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9446826/
https://www.ncbi.nlm.nih.gov/pubmed/36064338
http://dx.doi.org/10.1186/s12885-022-10016-5

Ejemplares similares